Acanthosis nigricans in the pediatric population: a narrative review of the current approach to management in primary care
- PMID: 36420374
- PMCID: PMC9678372
- DOI: 10.21037/pm-21-70
Acanthosis nigricans in the pediatric population: a narrative review of the current approach to management in primary care
Abstract
Objective: This narrative review aims to provide readers with a comprehensive overview of the current literature of acanthosis nigricans (AN) in the pediatric and adolescent population, including best practices for identifying the condition, with a focus on the recommended management in the primary care setting to enable early and enhanced intervention.
Background: AN is frequently seen in obese and overweight children and adolescents. Current research suggests an association with insulin resistance, type 2 diabetes mellitus, and obesity, and often primary care physicians are the first point of contact for individuals with this dermatologic condition. However, identifying the condition at an early stage may be difficult.
Methods: We identified case and cross-sectional studies, clinical trials, and literature reviews of pediatric AN for ages 0 to 18 years in the United States and internationally. We considered publications for background from before the year 2000 and publications for approach to management from after the year 2000.
Conclusions: AN in the pediatric population can be a harbinger for underlying metabolic syndrome and insulin resistance. A thorough investigation and appropriate screening of children at risk, with a focus on early identification of the dermatologic condition and its associated comorbidities in the primary care setting, and early treatment is recommended to prevent long term consequences and decrease the risk of cardiovascular complications.
Keywords: Acanthosis nigricans (AN); insulin resistance; multidisciplinary care; obesity.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/pm-21-70). The authors have no conflicts of interest to declare.
Figures
References
-
- Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31:1–19; quiz 20–2. - PubMed
-
- Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 2000;23:381–9. - PubMed
-
- Abraham C, Rozmus CL. Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review. J Sch Nurs 2012;28:195–205. - PubMed
-
- Stulberg DL, Clark N, Tovey D. Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation. Am Fam Physician 2003;68:1963–8. - PubMed